CluePoints, a provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has entered into an enterprise agreement with Japan’s ONO Pharmaceutical Co., Ltd. ONO will utilize CluePoints’ centralized statistical monitoring (CSM) platform for a four-year period to help create efficiencies by using advanced statistical methodologies to identify the sites and patients where monitoring is most needed.   CluePoints and ONO will now continue to work to build on th...